Non-valvular Atrial Fibrillation

• CLINICAL_TRIALS trial_result · 2019-08-19
  Clinical Trial Update: Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN) [Phase 4]

  Phase 4 trial assessing an education and guidance programme to promote Eliquis (apixaban) adherence in non-valvular atrial fibrillation.

• CLINICAL_TRIALS trial_result · 2019-01-30
  Clinical Trial Update: A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

  A completed real-world study comparing safety and effectiveness of NOAC-naïve versus warfarin-naïve patients with non-valvular atrial fibril…

• CLINICAL_TRIALS trial_result · 2017-07-11
  Clinical Trial Update: A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure [Phase 4]

  A Phase 4 trial is evaluating edoxaban in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure; the trial…

• CLINICAL_TRIALS trial_result · 2017-06-08
  Clinical Trial Update: The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

  Clinical trial update comparing safety and effectiveness of warfarin versus dabigatran in adults with non-valvular atrial fibrillation withi…

• CLINICAL_TRIALS trial_result · 2016-12-20
  Clinical Trial Update: Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2

  REACT-AF2 is a completed real-world evidence study evaluating anticoagulation treatment in non-valvular atrial fibrillation across Germany, …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-06-07
  Clinical Trial Update: Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

  This clinical trial update analyzes discontinuation rates, adherence patterns, hospitalizations, and costs associated with oral anticoagulan…

• CLINICAL_TRIALS trial_result · 2016-02-17
  Clinical Trial Update: Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation [Phase 4]

  This Phase 4 clinical trial compares the efficacy and safety of dabigatran, rivaroxaban, and apixaban in patients with non-valvular atrial f…

• CLINICAL_TRIALS trial_result · 2015-01-26
  Clinical Trial Update: Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment [Phase 3]

  Phase 3 safety and pharmacokinetics study of DU-176b in non-valvular atrial fibrillation patients with severe renal impairment has been comp…

• CLINICAL_TRIALS trial_result · 2015-01-15
  Clinical Trial Update: Coherex WAVECREST I Left Atrial Appendage Occlusion Study

  The WAVECREST I trial evaluating left atrial appendage occlusion in non-valvular atrial fibrillation has completed. The update notes the stu…

• CLINICAL_TRIALS trial_result · 2012-05-21
  Clinical Trial Update: The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation [Phase 4]

  A Phase 4 study evaluating different intensity anticoagulation regimens in elderly patients with non-valvular atrial fibrillation has comple…

• CLINICAL_TRIALS trial_result · 2011-12-19
  Clinical Trial Update: Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation [Phase 2]

  Phase 2 clinical trial of YM150, a direct Factor Xa inhibitor from Astellas, for prevention of stroke in non-valvular atrial fibrillation ha…